...
机译:曲妥珠单抗对化疗及放疗治疗人体表皮生长因子受体2-过度抑制乳腺癌患者的型患者的影响
Department of Radiation Oncology Seoul National University Hospital;
Department of Radiation Oncology Seoul National University Hospital;
Department of Radiation Oncology Seoul National University Hospital;
Department of Radiation Oncology Ewha Womans University College of Medicine;
Department of Radiation Oncology Seoul National University College of Medicine;
Department of Internal Medicine Seoul National University College of Medicine;
Department of Internal Medicine Seoul National University College of Medicine;
Department of Internal Medicine Seoul National University College of Medicine;
Trastuzumab; Locoregional control; Radiotherapy; Modern chemotherapy;
机译:曲妥珠单抗对化疗及放疗治疗人体表皮生长因子受体2-过度抑制乳腺癌患者的型患者的影响
机译:对患有人类表皮生长因子受体2-过表达的乳腺癌患者进行激素治疗和不化疗的新辅助拉帕替尼和曲妥珠单抗的多中心II期研究:TBCRC 006。
机译:辅助曲妥珠单抗对乳房切除术治疗的人表皮生长因子受体2-阳性乳腺癌局部复发的影响
机译:人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
机译:表皮生长因子受体过表达作为乳腺癌成像和放射治疗的目标。
机译:铟-111-放射性标记曲妥珠单抗在人表皮生长因子受体2-过表达乳腺癌患者中的治疗前生物分布和剂量学研究
机译:曲妥珠单抗对化疗和放射治疗治疗人体表皮生长因子受体2-过度抑制乳腺癌患者型患者的影响